AMSTERDAM, June 23, 2014 /PRNewswire/ --
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of a Simplified Chinese user interface to Scopus, the largest abstract and citation database of peer-reviewed literature. The interface enables Chinese users to search and discover scientific literature in their local language.
In addition to the localized interface, all Scopus help files have been translated into Simplified Chinese to ease product understanding amongst users. Customers in mainland China are now able to find the research information they are looking for more efficiently and to expand beyond Scopus' basic search functionalities to utilize more advanced features such as alerts, the Journal Analyzer and the Analyze Results functionality. For librarians in China, the localized interface will improve both their ability to train users on Scopus and the usability of Scopus.
Cameron Ross, Vice President of Product Management for Scopus and Engineering Village at Elsevier, said, "With a wide range of global content coverage and functionality, Scopus has become one of the most popular abstract and citation databases amongst researchers. We are delighted to be able to further meet the needs of our Chinese customers and users with the launch of the Simplified Chinese user interface."Christopher Yeow Tze Yian, Elsevier's Science & Technology Research Solutions Sales Director for China mainland, Hong Kong and Macao, said, "This local-language interface will help our Chinese users accelerate the pace of their research, conduct analysis and determine their research strategy in a more efficient and effective way. Similarly, the Simplified Chinese interface supports researchers to efficiently gain information critical to developing their academic careers. To view the interface, go to http://www.scopus.com and select the Simplified Chinese interface from the footer or set your browser to Simplified Chinese. About Scopus Scopus, the largest abstract and citation database of peer-reviewed literature, features smart tools to track, analyze and visualize scholarly research. Its vast database contains abstracts and references from 21,000 titles from more than 5,000 publishers worldwide, ensuring broad interdisciplinary coverage in the fields of science, technology, medicine, social sciences and Arts & Humanities. Scopus was designed and developed with input from researchers and librarians internationally; and features direct links to subscribed full-text articles, other library resources and interoperability with applications such as reference management software. About Elsevier Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions - among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey - and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works. The company is part of Reed Elsevier Group PLC, a world-leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange). Media contact Harald Boersma Director, Corporate Relations, Elsevier +31-20-485-27-36 firstname.lastname@example.org SOURCE Elsevier
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV